Porton Pharma Solutions is a global CDMO headquartered in China with over 4,300 employees and operations in the US, Europe (Slovenia), and China. They offer end-to-end services across small molecules, tides (peptides/oligonucleotides), biologics and conjugates (ADCs), and advanced therapy medicinal products. Technical solutions include crystallization, bio catalysis, metal catalysis, flow chemistry, preparative chromatography, milling, and chemical engineering. FDA-registered with 4 FEI numbers for API manufacture, they have 3 FDA inspections with clean outcomes (1 NAI, 2 VAI).
small molecule API synthesis, peptide/oligonucleotide CDMO, ADC manufacturing, flow chemistry, biocatalysis, metal catalysis, crystallization, global CDMO with multi-site operations
2 sites worldwide
No reviews available yet.
No documents available.